Larvol Delta - Cognition-Therapeutics-to-Report-Biomarker-Results-from-Phase-2-SHINE-Study-in-MildtoModerate-Alzheimers-Disease-in-Podium-Presentation-at-ADPD-2025

Elayta (zervimesine) - Cognition Therap

https://www.globenewswire.com/news-release/2025/03/25/3048620/0/en/Cognition-Therapeutics-to-Report-Biomarker-Results-from-Phase-2-SHINE-Study-in-Mild-to-Moderate-Alzheimer-s-Disease-in-Podium-Presentation-at-AD-PD-2025.html

Mar 25, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next